Adia Nutrition's diverse portfolio, including its groundbreaking work in stem cell therapy through Adia Med, has positioned ...
This strategic move is part of Adia's plan to uplist its shares from the OTC Pink Sheets to the OTCQB Venture Market, aiming to enhance visibility, attract a broader investor base, and reflect the ...
The Company's reduction in Authorized Shares should be effective within the next few weeks. The Company's transfer agent will adjust the Company's records to reflect the reduction and will report the ...
is pleased to announce its intentions to uplist from The OTC Pink Sheets to The OTCQB Venture Market. The company's stock will continue to trade under the ticker symbol "CTTH". CTT Pharma will ...
This transaction eliminates the Company's secured debt and redeems all its Series C Preferred Stock while positioning the Company for new growth opportunities ...